[HTML][HTML] Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease

Neurología (english Edition), 2022 - Elsevier
Introduction Worldwide, approximately 50 million people have dementia, with Alzheimer
disease (AD) being the most common type, accounting for 60%-70% of cases. Given its high …

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease

PC Bello-Medina, DA González-Franco… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Worldwide, approximately 50 million people have dementia, with Alzheimer
disease (AD) being the most common type, accounting for 60%-70% of cases. Given its high …

[PDF][PDF] Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease

PC Bello-Medina, DA González-Franco… - 2019 - researchgate.net
Introduction: Worldwide, approximately 50 million people have dementia, with Alzheimer
disease (AD) being the most common type, accounting for 60%-70% of cases. Given its high …

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.

PC Bello-Medina, DA González-Franco… - Neurologia, 2021 - europepmc.org
Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models
of Alzheimer disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.

PC Bello-Medina, DA González-Franco… - Neurologia, 2019 - europepmc.org
Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models
of Alzheimer disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease

PC Bello-Medina, DA González-Franco… - … - pubmed.ncbi.nlm.nih.gov
Introduction Worldwide, approximately 50 million people have dementia, with Alzheimer
disease (AD) being the most common type, accounting for 60%-70% of cases. Given its high …